1. Home
  2. NKTX vs DGXX Comparison

NKTX vs DGXX Comparison

Compare NKTX & DGXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • DGXX
  • Stock Information
  • Founded
  • NKTX 2015
  • DGXX 2017
  • Country
  • NKTX United States
  • DGXX United States
  • Employees
  • NKTX N/A
  • DGXX N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • DGXX
  • Sector
  • NKTX Health Care
  • DGXX
  • Exchange
  • NKTX Nasdaq
  • DGXX NYSE
  • Market Cap
  • NKTX 123.5M
  • DGXX 106.6M
  • IPO Year
  • NKTX 2020
  • DGXX N/A
  • Fundamental
  • Price
  • NKTX $2.12
  • DGXX $2.79
  • Analyst Decision
  • NKTX Strong Buy
  • DGXX Strong Buy
  • Analyst Count
  • NKTX 6
  • DGXX 1
  • Target Price
  • NKTX $14.40
  • DGXX $2.50
  • AVG Volume (30 Days)
  • NKTX 578.6K
  • DGXX 2.7M
  • Earning Date
  • NKTX 08-12-2025
  • DGXX 08-14-2025
  • Dividend Yield
  • NKTX N/A
  • DGXX N/A
  • EPS Growth
  • NKTX N/A
  • DGXX N/A
  • EPS
  • NKTX N/A
  • DGXX N/A
  • Revenue
  • NKTX N/A
  • DGXX $33,320,531.00
  • Revenue This Year
  • NKTX N/A
  • DGXX N/A
  • Revenue Next Year
  • NKTX N/A
  • DGXX N/A
  • P/E Ratio
  • NKTX N/A
  • DGXX N/A
  • Revenue Growth
  • NKTX N/A
  • DGXX N/A
  • 52 Week Low
  • NKTX $1.31
  • DGXX $0.85
  • 52 Week High
  • NKTX $6.66
  • DGXX $4.25
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 57.92
  • DGXX N/A
  • Support Level
  • NKTX $1.74
  • DGXX N/A
  • Resistance Level
  • NKTX $2.32
  • DGXX N/A
  • Average True Range (ATR)
  • NKTX 0.15
  • DGXX 0.00
  • MACD
  • NKTX 0.02
  • DGXX 0.00
  • Stochastic Oscillator
  • NKTX 62.96
  • DGXX 0.00

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About DGXX DIGI POWER X INC

Digi Power X Inc is an infrastructure company that develops cutting-edge data centers to drive the expansion of sustainable energy assets. The company focuses on expanding power infrastructure to create a resilient backbone for the future of energy and technology.

Share on Social Networks: